We have launched the standard of vicious tumor of hematopoietic system, involving bone marrow hyperplasia abnormal syndrome (MDS)/bone marrow proliferative tumor (MPN)/acute marrow leukemia (AML)/chronic granulocyte leukemia (CML)/chronic lymphocyte leukemia ( CLL)/acute lymphocytic leukemia (ALL) and other common genetic mutation points related to diseases.

Fig 1. Common blood system malignant tumor classification and related genetic sites

    In order to thank you for your trust and support for us you have launched the "New Product Trial" activity. 10 places, first come first, first, welcome to actively apply for a trial dress. For the application method, see the end of the article.

    This is a multi -gene and multi -digit Panel standard product. The raw materials used in mixed samples are basically derived from the blood system -related tumor samples. Kai Bai Bio has 38 bit -related points related to 27 genes, all of which have developed a digital PCR (DDPCR) detection system, and accurately standardized the mutant frequency or copy number variation value corresponding to the benchmark. And most of the mutations are pathological significance.

Table 1. 27 genes related to Panel related to the blood system malignant tumor Panel

    Most of the insertions and lack of duplicate bases are repeated), 4 DNAs are rearranged, and 1 copy number mutation.

Fig 2. Mutation types corresponding to 38 sites